vs
Ranpak Holdings Corp.（PACK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Ranpak Holdings Corp.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$93.7M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 2.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.7%）
Ranpak Holdings Corp.主营生产防护纸质包装设备与纸制品，可为电商及各行业货品运输提供纸质缓冲包装方案，同时也供应自动化包装解决方案。公司总部位于美国俄亥俄州康科德，在美国本土多个州、捷克、荷兰、中国上海及新加坡均设有生产基地与办公室，产品可用于包裹缠绕、缓冲填隙、冷链运输等多种场景。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PACK vs RIGL — 直观对比
营收规模更大
PACK
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出18.9%
2.3%
两年增速更快
RIGL
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.7M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 39.0% | 91.5% |
| 营业利润率 | -1.0% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 2.3% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-0.11 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACKRIGL
| Q4 25 | $93.7M | $69.8M | ||
| Q3 25 | $83.6M | $69.5M | ||
| Q2 25 | $77.8M | $101.7M | ||
| Q1 25 | $77.6M | $53.3M | ||
| Q4 24 | $91.6M | $57.6M | ||
| Q3 24 | $78.6M | $55.3M | ||
| Q2 24 | $72.8M | $36.8M | ||
| Q1 24 | $72.5M | $29.5M |
净利润PACKRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-10.4M | $27.9M | ||
| Q2 25 | $-7.5M | $59.6M | ||
| Q1 25 | $-10.9M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-8.1M | $12.4M | ||
| Q2 24 | $5.5M | $-1.0M | ||
| Q1 24 | $-8.1M | $-8.2M |
毛利率PACKRIGL
| Q4 25 | 39.0% | 91.5% | ||
| Q3 25 | 41.1% | 93.2% | ||
| Q2 25 | 37.1% | 95.6% | ||
| Q1 25 | 39.8% | 91.7% | ||
| Q4 24 | 45.2% | 89.9% | ||
| Q3 24 | 43.8% | 85.5% | ||
| Q2 24 | 43.5% | 92.4% | ||
| Q1 24 | 44.6% | 93.1% |
营业利润率PACKRIGL
| Q4 25 | -1.0% | 33.2% | ||
| Q3 25 | -6.8% | 40.9% | ||
| Q2 25 | -12.5% | 60.1% | ||
| Q1 25 | -10.3% | 23.9% | ||
| Q4 24 | 1.5% | 28.9% | ||
| Q3 24 | -5.3% | 25.4% | ||
| Q2 24 | -7.1% | 1.2% | ||
| Q1 24 | -6.6% | -23.6% |
净利率PACKRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -12.4% | 40.2% | ||
| Q2 25 | -9.6% | 58.6% | ||
| Q1 25 | -14.0% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -10.3% | 22.5% | ||
| Q2 24 | 7.6% | -2.8% | ||
| Q1 24 | -11.2% | -27.9% |
每股收益（稀释后）PACKRIGL
| Q4 25 | $-0.11 | $14.11 | ||
| Q3 25 | $-0.12 | $1.46 | ||
| Q2 25 | $-0.09 | $3.28 | ||
| Q1 25 | $-0.13 | $0.63 | ||
| Q4 24 | $-0.13 | $0.82 | ||
| Q3 24 | $-0.10 | $0.70 | ||
| Q2 24 | $0.07 | $-0.06 | ||
| Q1 24 | $-0.10 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.0M | $155.0M |
| 总债务越低越好 | $401.9M | $52.5M |
| 股东权益账面价值 | $534.9M | $391.5M |
| 总资产 | $1.1B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.75× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PACKRIGL
| Q4 25 | $63.0M | $155.0M | ||
| Q3 25 | $49.9M | $137.1M | ||
| Q2 25 | $49.2M | $108.4M | ||
| Q1 25 | $65.5M | $77.1M | ||
| Q4 24 | $76.1M | $77.3M | ||
| Q3 24 | $69.5M | $61.1M | ||
| Q2 24 | $65.1M | $49.1M | ||
| Q1 24 | $55.1M | $49.5M |
总债务PACKRIGL
| Q4 25 | $401.9M | $52.5M | ||
| Q3 25 | $403.1M | $60.0M | ||
| Q2 25 | $403.1M | $60.0M | ||
| Q1 25 | $405.2M | $60.0M | ||
| Q4 24 | $406.4M | $60.0M | ||
| Q3 24 | $403.2M | $60.0M | ||
| Q2 24 | $396.1M | $60.0M | ||
| Q1 24 | $396.7M | $60.0M |
股东权益PACKRIGL
| Q4 25 | $534.9M | $391.5M | ||
| Q3 25 | $537.8M | $117.6M | ||
| Q2 25 | $539.0M | $81.9M | ||
| Q1 25 | $544.1M | $18.6M | ||
| Q4 24 | $548.1M | $3.3M | ||
| Q3 24 | $564.3M | $-14.6M | ||
| Q2 24 | $566.2M | $-29.9M | ||
| Q1 24 | $560.0M | $-31.7M |
总资产PACKRIGL
| Q4 25 | $1.1B | $513.6M | ||
| Q3 25 | $1.1B | $242.5M | ||
| Q2 25 | $1.1B | $206.7M | ||
| Q1 25 | $1.1B | $176.0M | ||
| Q4 24 | $1.1B | $164.0M | ||
| Q3 24 | $1.1B | $139.4M | ||
| Q2 24 | $1.1B | $128.4M | ||
| Q1 24 | $1.1B | $126.5M |
负债/权益比PACKRIGL
| Q4 25 | 0.75× | 0.13× | ||
| Q3 25 | 0.75× | 0.51× | ||
| Q2 25 | 0.75× | 0.73× | ||
| Q1 25 | 0.74× | 3.23× | ||
| Q4 24 | 0.74× | 18.25× | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PACKRIGL
| Q4 25 | $19.5M | $22.0M | ||
| Q3 25 | $8.5M | $24.0M | ||
| Q2 25 | $-3.6M | $30.5M | ||
| Q1 25 | $-1.3M | $-893.0K | ||
| Q4 24 | $6.5M | $14.5M | ||
| Q3 24 | $10.1M | $21.7M | ||
| Q2 24 | $19.6M | $302.0K | ||
| Q1 24 | $5.2M | $-5.0M |
现金转化率PACKRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 3.56× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
RIGL
暂无分部数据
